This CLE program explores the rapidly developing field of cannabis-related product liability and personal injury litigation. As the commercial THC market expands nationwide, courts are beginning to confront claims involving addiction, psychiatric injury, cognitive impairment, and other alleged harms associated with high-potency cannabis products.

The course examines the evidentiary and legal theories shaping this emerging docket, including failure to warn, design defect, negligent marketing, consumer protection violations, and public nuisance claims. Participants will analyze how plaintiffs are framing allegations concerning industry knowledge of risk, product potency, and marketing practices, as well as the defenses likely to be asserted by manufacturers, distributors, and retailers.

In addition to substantive law, the program addresses practical litigation considerations—causation challenges, expert development, regulatory overlay, federal-state tensions, and damages modeling. Attendees will gain a working understanding of the strategic, scientific, and procedural issues that define cannabis-related injury cases and will leave equipped to evaluate and litigate claims arising from THC products.